Book a Call

Please enable JavaScript in your browser to complete this form.
Name
By signing up, you agree to receive emails and communications from SEBERS Medical. Unsubscribe anytime.
Edit Template

Blossom TMS Spotlight

  • All Post
  • Blossom TMS Spotlight
  • TMS Therapy
  • Uncategorized
Blossom TMS Spotlight: Interview with Dr. Alex Lazar – Bliss TMS

September 9, 2024/

Welcome to the Blossom Provider Spotlight series, where we highlight outstanding providers in the mental health field. This week, we’re thrilled to feature Dr. Alex Lazar, a highly experienced psychiatrist based in Encino, California. With over two decades of practice in adult and child psychiatry, Dr. Lazar has recently expanded his treatment offerings…

Blossom Provider Spotlight: An Interview with Casey Dubravcic from Revitalize Ketamine Clinic

September 9, 2024/

Welcome to the Blossom Provider Spotlight series, where we highlight exceptional providers in the mental health field. This week, we’re excited to feature Casey Dubravcic, owner and operator of Revitalize Ketamine Clinic. Based in Flagstaff, Arizona, with additional locations in Sedona and Prescott Valley, Casey and his team are dedicated to offering innovative…

Blossom Burst Magazine Feature: rTMS Therapy for Depression

September 9, 2024/

A Primer on Its Physical Principles, Practicalities, Protocols and Evidence Base Authors: Leo Chen and Linda L. Carpenter Excerpt from our magazine: This blog post is an excerpt from our magazine. For a free digital or print version to read the full article and much more, visit us at https://sebersmedical.com/. Introduction Repetitive transcranial magnetic…

CONTACT INFO

Phone: 833.3BUY.TMS (+1.833.3289.867)

Email: Sales@sebersmedical.com

Address: 230 S Broad Street, 17th Floor Philadelphia, PA 19102

QUICK LINKS

LEGAL

Disclaimer:

Regulations in the United States

*United States Federal Law regulates the sale of Medical Devices. The Blossom TMS Therapy System is indicated for the treatment of Major Depressive Disorder in adult patients, who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. (K220625) All other devices on this website are not approved and/or cleared for use in treatment and/or diagnosis in the United States. All investigational devices must be labeled in accordance with the labeling requirements of the IDE regulation (§ 812.5) and bear a label that states:
“CAUTION.
Investigational Device. Restricted by federal (or United States) law to research use.”